MCF Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.5K Sell
46,500
-23,500
-34% -$33.9K ﹤0.01% 550
2026
Q1
$88.9K Hold
70,000
﹤0.01% 515
2025
Q4
$167K Sell
70,000
-5,000
-7% -$13.7K 0.01% 339
2025
Q3
$214K Buy
75,000
+50,000
+200% +$171K 0.01% 239
2025
Q2
$94.3K Hold
25,000
0.01% 318
2025
Q1
$113K Buy
+25,000
New +$132K 0.01% 288

Other funds holding HCAT

MCF Advisors's HCAT Position: Q2 2026 in Review

MCF Advisors reduced its Health Catalyst (HCAT) stake by 34% in Q2 2026, selling an estimated $33.9K and leaving 46,500 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

MCF Advisors first reported a position in HCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $214K in Q3 2025. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • MCF Advisors held 46,500 shares of Health Catalyst worth $92.5K as of Q2 2026.
  • MCF Advisors sold 23,500 Health Catalyst shares in Q2 2026, an estimated $33.9K.
  • Health Catalyst made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #550 holding.
  • MCF Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 6 quarters since.
  • MCF Advisors's Health Catalyst position peaked at $214K in Q3 2025.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.